Sort
64,565 grants matching “drug discovery”
Genetic modifiers of atherosclerosis and macrophage phenotypes
$618,808Jonathan D Smith · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · HL
Disease-Modifying Genes in Huntington's Diseae
$618,776James F Gusella · Massachusetts General Hospital · R01 · FY2015 · NS
Clinical Core
$618,699C Robert Horsburgh · Rbhs-New Jersey Medical School · U19 · FY2020 · AI
Non Alcoholic Steatohepatitis Clinical Research Network
$618,611Srinivasan Dasarathy · Cleveland Clinic Lerner Com-Cwru · U01 · FY2022 · DK
Whole Genome Sequencing to Identify Causal Genetic Variants Influencing CVD Risk
$618,608John Blangero · Texas Biomedical Research Institute · R01 · FY2012 · HL
Targeting the casein kinase 1 (CK1)-like kinase Yck2 in fungal pathogenesis
$618,537Leah Elizabeth Cowen · University Of Toronto · R01 · FY2024 · AI
The multiple antibiotic resistance (Mar) regulon
$618,515Stuart B. Levy · Tufts University Boston · R01 · FY2011 · AI
REV-ERB ligands for treatment of anxiety disorders
$618,458Thomas P Burris · Saint Louis University · R01 · FY2014 · MH
Epigenetics-Based Autism Treatment with Animal Models and Human Stem Cells
$618,417Zhen Yan · State University Of New York At Buffalo · R01 · FY2025 · NS
Functional characterization of SSRI resistant genes using C. elegans
$618,408Ji Y Sze · Albert Einstein College Of Medicine · R01 · FY2009 · MH
Molecular identity of exosomal BK channels
$618,334Harpreet Singh · Ohio State University · R01 · FY2023 · HL
Elucidating Roles of Distinct Spinal Cord Cell types in Mediating Interstitial Cystitis (IC)/Bladder Pain Syndrome (BPS)
$618,296Vijay K Samineni · Washington University · R01 · FY2025 · DK
Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics
$618,244David R Liu · Broad Institute, Inc. · R35 · FY2017 · GM
CAREER: Biosynthesis and Evolution of Pharmaceutical Leads
$618,105Jerome M Fox · University Of Colorado At Boulder · · FY2018 · ENG
Structure-based inhibition of chemokine signaling in the inflamed pancreas
$617,998Brian F Volkman · Medical College Of Wisconsin · R01 · FY2024 · DK
Integrative Omics analysis of human cartilage in aging and osteoarthritis
$617,994Martin K. Lotz · Scripps Research Institute, The · R01 · FY2018 · AG
Integrative Omics analysis of human cartilage in aging and osteoarthritis
$617,994Martin K. Lotz · Scripps Research Institute, The · R01 · FY2019 · AG
Taking aim at HBV eradication using novel NRTIs and Capsid effectors
$617,972Stefan G Sarafianos · University Of Missouri-Columbia · R01 · FY2016 · AI
Understanding Treatment Response Patterns And Therapy Resistance In IDH-Mutant AML
$617,933Ann-Kathrin Eisfeld · Ohio State University · R01 · FY2024 · CA
Discovering Novel Drug Targets for CNS Edema by In Vitro Genetics
$617,925Ted Choi · Predictive Biology · R44 · FY2019 · NS
Characterization of novel insulin resistance genes by gene editing, high-throughput phenotyping and in vivo studies
$617,918Joshua Wiley Knowles · Stanford University · R01 · FY2022 · DK
NIH Center for Regenerative Medicine
$617,890Mahendra Rao · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2013 · AR
Validation of an in vitro model of progressive fibrosis that mimics Idiopathic Pulmonary Fibrosis
$617,814Brigitte N Gomperts · University Of California Los Angeles · U01 · FY2024 · HL
AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS
$617,796Ernesto Guccione · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA
AN INTEGRATED PLATFORM FOR NOVEL PERSONALIZED LIVER CANCER THERAPEUTICS
$617,796Ernesto Guccione · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA